tiprankstipranks
Trending News
More News >
Advertisement

SMIN - AI Analysis

Compare

Top Page

SMIN

iShares MSCI India Small Cap ETF (SMIN)

Rating:59Neutral
Price Target:
$78.00
The iShares MSCI India Small Cap ETF (SMIN) has a moderate overall rating, reflecting a mix of strengths and weaknesses among its holdings. Fortis Healthcare Ltd. and Embassy Office Parks REIT stand out as strong contributors, driven by robust financial performance, consistent revenue growth, and favorable technical analysis. However, weaker holdings like Glenmark Pharmaceuticals, with profitability challenges and bearish momentum, may have held back the fund’s rating. A key risk factor is the potential overvaluation across several holdings, which could impact future growth.
Positive Factors
Strong Sector Diversification
The ETF is spread across multiple sectors, including materials, healthcare, and financials, reducing reliance on any single industry.
Focused Geographic Exposure
With nearly all assets invested in India, the fund provides targeted exposure to a growing emerging market economy.
Healthy Top Holdings Performance
Several top holdings, such as Fortis Healthcare and Laurus Labs, have shown strong year-to-date gains, supporting the fund’s potential recovery.
Negative Factors
High Expense Ratio
The ETF charges a relatively high fee compared to many other funds, which can eat into investor returns over time.
Weak Overall Performance
The fund has struggled recently, with negative year-to-date and three-month returns, signaling potential challenges in the small-cap segment.
Over-Concentration in India
The ETF’s heavy focus on Indian stocks limits diversification and increases vulnerability to country-specific risks.

SMIN vs. SPDR S&P 500 ETF (SPY)

SMIN Summary

The iShares MSCI India Small Cap ETF (SMIN) is an investment fund that focuses on small companies in India, offering exposure to the country’s fast-growing economy. It follows the MSCI India Small Cap Index, which includes businesses across various sectors like healthcare, financials, and technology. Some of its well-known holdings include Fortis Healthcare and Federal Bank. This ETF is ideal for investors looking to diversify their portfolio and tap into the growth potential of smaller, innovative companies in emerging markets. However, it’s important to note that small-cap stocks can be more volatile, meaning their value may rise and fall quickly.
How much will it cost me?The iShares MSCI India Small Cap ETF (SMIN) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is an actively managed fund focusing on small-cap stocks in India, which require more research and management compared to passively managed funds.
What would affect this ETF?The iShares MSCI India Small Cap ETF (SMIN) could benefit from India's strong economic growth and increasing innovation in sectors like technology and healthcare, which are key areas of exposure for the fund. However, risks include potential regulatory changes in India, global economic uncertainty, and the inherent volatility of small-cap stocks, which can be more sensitive to market fluctuations. Investors should also consider how interest rate changes or inflation could impact sectors like financials and consumer goods within the ETF.

SMIN Top 10 Holdings

The iShares MSCI India Small Cap ETF (SMIN) is tapping into India’s vibrant small-cap market, but performance is a mixed bag. Fortis Healthcare is a bright spot, rising steadily thanks to strong financials and market momentum, while Laurus Labs is showing promise with consistent revenue growth. On the flip side, Coforge Limited is losing steam, weighed down by valuation concerns and weak technical signals. The fund leans toward sectors like healthcare, materials, and financials, offering a diverse slice of India’s economy. With all holdings rooted in India, SMIN is a pure play on this emerging market’s growth story.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Coforge Limited1.50%$14.24M₹589.11B18.77%
66
Neutral
Fortis Healthcare Ltd.1.37%$13.02M₹782.78B74.54%
64
Neutral
Max Financial Services Limited1.12%$10.62M₹523.35B19.62%
57
Neutral
Federal Bank Ltd. (India)1.12%$10.60M₹553.46B26.66%
66
Neutral
One 97 Communications Ltd.1.10%$10.47M₹822.24B78.20%
54
Neutral
GE Vernova T&D India Limited1.00%$9.51M₹743.87B72.29%
62
Neutral
Embassy Office Parks REIT1.00%$9.43M₹410.71B10.38%
76
Outperform
Laurus Labs Ltd.0.88%$8.30M₹499.47B90.81%
55
Neutral
Blue Star Limited0.73%$6.87M₹412.38B8.55%
73
Outperform
KEI Industries Limited0.69%$6.58M₹394.47B6.37%
70
Outperform

SMIN Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
73.58
Positive
100DMA
74.38
Positive
200DMA
71.65
Positive
Market Momentum
MACD
0.40
Negative
RSI
55.30
Neutral
STOCH
49.72
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMIN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 73.62, equal to the 50-day MA of 73.58, and equal to the 200-day MA of 71.65, indicating a bullish trend. The MACD of 0.40 indicates Negative momentum. The RSI at 55.30 is Neutral, neither overbought nor oversold. The STOCH value of 49.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMIN.

SMIN Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$897.46M0.75%
59
Neutral
$9.58B0.62%
65
Neutral
$2.89B0.84%
67
Neutral
$692.39M0.65%
67
Neutral
$215.54M0.78%
68
Neutral
$191.98M0.80%
63
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SMIN
iShares MSCI India Small Cap ETF
74.53
-1.64
-2.15%
INDA
iShares MSCI India ETF
EPI
WisdomTree India Earnings Fund
INDY
iShares India 50 ETF
PIN
Invesco India ETF
NFTY
First Trust India NIFTY 50 Equal Weight ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement